| TRADING CENTER |
| The Highest Possible Returns. Period. - MotleyFool.com | |
| J&J stays true to its diversified model - FT.com | |
| Now's a Great Time to Invest -- So Don't Blow It Like This - MotleyFool.com | |
| 5 Stocks Geared for Growth - MotleyFool.com | |
| 5 Stocks Making Cash - MotleyFool.com | |
| A Big Upgrade for Sanofi-Aventis - MotleyFool.com | |
| The Worst Stocks to Buy Today - MotleyFool.com | |
| The Hottest Sector for 2010 - MotleyFool.com | |
| 5-Star Stocks Poised to Pop: American Oriental Bioengineering - MotleyFool.com | |
| Gilead Awaits Committee Outcome - Analyst Blog - Zacks.com | |
| Gilead Sciences to Present at the Lazard Capital Markets 6TH Annual Healthcare Confer... - Business Wire | |
| 5-Star Stocks Worth a Look - MotleyFool.com | |
| Zacks Industry Outlook Highlights: Alcon, Novartis, Gilead Sciences, Biogen Idec and ... - Zacks.com | |
| A Big Upgrade for Gilead Sciences - MotleyFool.com | |
| Cramer on BloggingStocks: Pelosi can't kill the health care sector - Bloggingstocks.com |
| Last trade | Change/%change | P/E ratio | ||
|---|---|---|---|---|
| AMGN | Amgen Inc | 56.25 | 0.87 / 1.57% | 10.76 |
| CELG | Celgene Corporation | 55.65 | 0.74 / 1.35% | 67.05 |
| BIIB | Biogen Idec Inc | 46.79 | 0.41 / 0.88% | 15.70 |
| 2008 Revenue: | $5.3 B | Headquarters: Foster City, CA |
| Employees: | 3,441 | CEO: Dr. John C. Martin, M.D., Ph.D. |
| Net Income: | $2.0 B | Industry: Biotechnology |
| Market Cap: | $41.7 B | Website: www.gilead.com |
| Symbol | Price | Change/%Change | Prev. close | High | Low | Last Update | More Info |
|---|---|---|---|---|---|---|---|
| GILD | 47.01 | +0.62 / +1.34% | 46.39 | 47.13 | 46.54 | Profile Chart News |